Genome based subtyping identifies Parkinson’s disease subtypes with reproducible motor progression differences and clinical trial enrichment potential
This study demonstrates that genome-based subtyping of early Parkinson's disease identifies three reproducible clusters with distinct motor progression rates and clinical outcomes, offering a strategy to enrich clinical trial cohorts and significantly reduce required sample sizes.